Journal
AMERICAN JOURNAL OF MEDICINE
Volume 123, Issue 3, Pages 275-280Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2009.05.017
Keywords
Bisphosphonates; Novel formulation; Patient compliance
Categories
Funding
- Novartis Pharmaceuticals Corporation, East Hanover, NJ
Ask authors/readers for more resources
BACKGROUND: The extent of the adoption of once-monthly bisphosphonates into general clinical practice is not known, nor is it known if the novel formulation improves adherence. METHODS: We analyzed administrative claims 2003-2006 from a large employer-based health insurance database for incident use of oral bisphosphonates and stratified users by daily, weekly, and monthly dosing regimen. We measured adherence as the medication possession ratio (MPR) during the first year of therapy. We compared patient characteristics by closing regimen and evaluated how the dosing regimen influenced the MPR. RESULTS: We identified 61,125 incident users of bisphosphonates (it = 1034 daily, n = 56,925 weekly, n = 3166 monthly). Monthly bisphosphonate users were, on average, slightly older than the other groups (mean age 66 years tor monthly users vs 65 years for weekly users or 66 years for daily users, P < .05) and more often lived in the North Central or South United States (76% vs 72% weekly users or 69% daily users, P<.05). There were no detectable differences among the closing groups in the history of serious gastrointestinal risk. comorbidity burden, or prior osteoporotic fractures. During the first year of bisphosphonate therapy, 49% of monthly users had MPR >= 80% compared with 49% of weekly users (not significant) or 23% of daily users (P <.0001). CONCLUSION: We found little evidence of preferential prescribing of monthly bisphosphonates to certain types of patients. Furthermore, we found no evidence of improved bisphosphonate adherence with monthly dosing relative to weekly dosing, although adherence with either weekly or monthly dosing was significantly better than with daily dosing. (C) 2010 Elsevier Inc. All rights reserved. . The American Journal of Medicine (2010) 123, 275-280
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available